Salivary alterations in insulin-dependent diabetes mellitus

M A Belazi1, A Galli-Tsinopoulou, D Drakoulakos

  • 1Aristotle University of Thessaloniki, School of Dentistry, Department of Oral Medicine/Pathology, Greece.

Insights

Children with new insulin-dependent diabetes mellitus (IDDM) show higher glucose levels in saliva and serum. Salivary composition changes may aid early IDDM diagnosis in children.

Area of Science:

  • Pediatric Endocrinology
  • Biochemistry
  • Clinical Diagnostics

Background:

  • Insulin-dependent diabetes mellitus (IDDM) diagnosis in children requires careful monitoring.
  • Saliva and serum biomarkers offer potential for early disease detection.

Purpose of the Study:

  • To compare salivary and serum glucose, protein, albumin, and immunoglobulin levels in newly diagnosed pediatric IDDM patients versus healthy controls.
  • To investigate the diagnostic potential of salivary composition in early-stage IDDM.

Main Methods:

  • Cross-sectional study involving 10 children with newly diagnosed IDDM (aged 4-15) and 10 healthy controls (aged 5-17).
  • Unstimulated whole saliva and serum samples were collected for analysis of glucose, total proteins, albumin, IgA, and IgG.
  • Clinical examinations were performed prior to sample collection.

Main Results:

  • No significant difference in salivary flow rate between IDDM patients and controls.
  • Significantly elevated glucose concentrations in both saliva and serum of children with IDDM.
  • Higher salivary IgA and serum IgG concentrations were observed in the IDDM group.
  • Total protein and albumin levels did not differ significantly between groups.

Conclusions:

  • Elevated salivary and serum glucose levels are characteristic of newly diagnosed pediatric IDDM.
  • Changes in salivary composition, including glucose and IgA, may assist in the early diagnosis of IDDM in children.
  • Further research is warranted to validate the diagnostic utility of salivary biomarkers for pediatric IDDM.
Abstract

Related Concept Videos

Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Insipidus II: Pathophysiology01:22

Diabetes Insipidus II: Pathophysiology

Normally, water balance is maintained through three interconnected mechanisms: the hypothalamic thirst center, the synthesis and release of antidiuretic hormone (ADH, or vasopressin), and the kidneys' responsiveness to this hormone. ADH is synthesized in the hypothalamus, released from the posterior pituitary, and acts on the distal nephron, allowing water reabsorption and concentrated urine production.Diabetes Insipidus and Its TypesIn diabetes insipidus (DI), this regulatory system is...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...